110 related articles for article (PubMed ID: 22814619)
1. CITED2 functions as a molecular switch of cytokine-induced proliferation and quiescence.
Chou YT; Hsieh CH; Chiou SH; Hsu CF; Kao YR; Lee CC; Chung CH; Wang YH; Hsu HS; Pang ST; Shieh YS; Wu CW
Cell Death Differ; 2012 Dec; 19(12):2015-28. PubMed ID: 22814619
[TBL] [Abstract][Full Text] [Related]
2. Sequential activation of NFAT and c-Myc transcription factors mediates the TGF-beta switch from a suppressor to a promoter of cancer cell proliferation.
Singh G; Singh SK; König A; Reutlinger K; Nye MD; Adhikary T; Eilers M; Gress TM; Fernandez-Zapico ME; Ellenrieder V
J Biol Chem; 2010 Aug; 285(35):27241-27250. PubMed ID: 20516082
[TBL] [Abstract][Full Text] [Related]
3. CITED2 Modulates Breast Cancer Metastatic Ability through Effects on IKKα.
Jayaraman S; Doucet M; Lau WM; Kominsky SL
Mol Cancer Res; 2016 Aug; 14(8):730-9. PubMed ID: 27216153
[TBL] [Abstract][Full Text] [Related]
4. Masking epistasis between MYC and TGF-β pathways in antiangiogenesis-mediated colon cancer suppression.
Dews M; Tan GS; Hultine S; Raman P; Choi J; Duperret EK; Lawler J; Bass A; Thomas-Tikhonenko A
J Natl Cancer Inst; 2014 Apr; 106(4):dju043. PubMed ID: 24627270
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic Stress Decreases c-Myc Protein Stability in Cardiac Progenitor Cells Inducing Quiescence and Compromising Their Proliferative and Vasculogenic Potential.
Bellio MA; Pinto MT; Florea V; Barrios PA; Taylor CN; Brown AB; Lamondin C; Hare JM; Schulman IH; Rodrigues CO
Sci Rep; 2017 Aug; 7(1):9702. PubMed ID: 28851980
[TBL] [Abstract][Full Text] [Related]
6. Roles and signaling pathways of CITED1 in tumors: overview and novel insights.
Chen W; Jiang J; Gao J; Wang G; Wang R; Lv J; Ben J
J Int Med Res; 2024 Jan; 52(1):3000605231220890. PubMed ID: 38190845
[TBL] [Abstract][Full Text] [Related]
7. Correction: In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis.
Arriaga JM; Ronaldson-Bouchard K; Picech F; Nunes de Almeida F; Afari S; Chhouri H; Vunjak-Novakovic G; Abate-Shen C
Oncogene; 2024 May; 43(21):1654. PubMed ID: 38627522
[No Abstract] [Full Text] [Related]
8. CITED2-mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia.
Korthuis PM; Berger G; Bakker B; Rozenveld-Geugien M; Jaques J; de Haan G; Schuringa JJ; Vellenga E; Schepers H
Leukemia; 2015 Mar; 29(3):625-35. PubMed ID: 25184385
[TBL] [Abstract][Full Text] [Related]
9. Cited2 is required in trophoblasts for correct placental capillary patterning.
Moreau JL; Artap ST; Shi H; Chapman G; Leone G; Sparrow DB; Dunwoodie SL
Dev Biol; 2014 Aug; 392(1):62-79. PubMed ID: 24803182
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of Cbp/P300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 inhibits cell division and increases apoptosis in gastric cancer.
Tang Z; He G; Xu J; Zhongfu L
J Surg Res; 2017 May; 211():1-7. PubMed ID: 28501104
[TBL] [Abstract][Full Text] [Related]
11. Gene expression network analysis reveals new transcriptional regulators as novel factors in human ischemic cardiomyopathy.
Herrer I; Roselló-Lletí E; Ortega A; Tarazón E; Molina-Navarro MM; Triviño JC; Martínez-Dolz L; Almenar L; Lago F; Sánchez-Lázaro I; González-Juanatey JR; Salvador A; Portolés M; Rivera M
BMC Med Genomics; 2015 Mar; 8():14. PubMed ID: 25884818
[TBL] [Abstract][Full Text] [Related]
12. Acute loss of Cited2 impairs Nanog expression and decreases self-renewal of mouse embryonic stem cells.
Kranc KR; Oliveira DV; Armesilla-Diaz A; Pacheco-Leyva I; Catarina Matias A; Luisa Escapa A; Subramani C; Wheadon H; Trindade M; Nichols J; Kaji K; Enver T; Bragança J
Stem Cells; 2015 Mar; 33(3):699-712. PubMed ID: 25377420
[TBL] [Abstract][Full Text] [Related]
13. Metabolic requirements for the maintenance of self-renewing stem cells.
Ito K; Suda T
Nat Rev Mol Cell Biol; 2014 Apr; 15(4):243-56. PubMed ID: 24651542
[TBL] [Abstract][Full Text] [Related]
14. Cited2 in hematopoietic stem cell function.
Du J; Yang YC
Curr Opin Hematol; 2013 Jul; 20(4):301-7. PubMed ID: 23507959
[TBL] [Abstract][Full Text] [Related]
15. CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth.
Cheung KF; Zhao J; Hao Y; Li X; Lowe AW; Cheng AS; Sung JJ; Yu J
Cancer; 2013 Mar; 119(6):1217-26. PubMed ID: 23212831
[TBL] [Abstract][Full Text] [Related]
16. CITED2 mediates the mechanical loading-induced suppression of adipokines in the infrapatellar fat pad.
Liu L; He Z; Xu L; Lu L; Feng H; Leong DJ; Kim SJ; Hirsh DM; Majeska RJ; Goldring MB; Cobelli NJ; Sun HB
Ann N Y Acad Sci; 2019 Apr; 1442(1):153-164. PubMed ID: 30891782
[TBL] [Abstract][Full Text] [Related]
17. Exploring the role of CITED transcriptional regulators in the control of macrophage polarization.
Wiggins DA; Maxwell JN; Nelson DE
Front Immunol; 2024; 15():1365718. PubMed ID: 38646545
[TBL] [Abstract][Full Text] [Related]
18. Enhancer infestation drives tumorigenic activation of inactive B compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma.
Mizokami H; Okabe A; Choudhary R; Mima M; Saeda K; Fukuyo M; Rahmutulla B; Seki M; Goh BC; Kondo S; Dochi H; Moriyama-Kita M; Misawa K; Hanazawa T; Tan P; Yoshizaki T; Fullwood MJ; Kaneda A
EBioMedicine; 2024 Apr; 102():105057. PubMed ID: 38490101
[TBL] [Abstract][Full Text] [Related]
19. In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis.
Arriaga JM; Ronaldson-Bouchard K; Picech F; Nunes de Almeida F; Afari S; Chhouri H; Vunjak-Novakovic G; Abate-Shen C
Oncogene; 2024 Apr; 43(17):1303-1315. PubMed ID: 38454137
[TBL] [Abstract][Full Text] [Related]
20. Inflammation and tumor microenvironment.
Niu T; Zhou F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 48(12):1899-1913. PubMed ID: 38448384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
